Abstract
The effects of enalapril on plasma lipoproteins were evaluated in an open study of 12 normolipidemic outpatients with mild-to-moderate essential hypertension (World Health Organization stages I and II). After a two-week washout period, during which placebo was given, the patients received 20 to 40 mg/day of enalapril for 16 weeks. Treatment with enalapril was associated with significant increases in levels of HDL cholesterol (mean, 23%; P2 (mean, 43%; P3 also rose (mean, 14%; P
| Original language | English |
|---|---|
| Pages (from-to) | 635-639 |
| Number of pages | 5 |
| Journal | Clinical Therapeutics |
| Volume | 9 |
| Issue number | 6 |
| Publication status | Published - 1987 |
Fingerprint
ASJC Scopus subject areas
- Pharmacology
Cite this
Perani, G., Muggia, C., Martignoni, A., Bongarzoni, A., Radaelli, A., Testa, F., & Finardi, G. (1987). Increase in plasma HDL-cholesterol in hypertensive patients treated with enalapril. Clinical Therapeutics, 9(6), 635-639.